NFKB1 and Parkinson disease: Consistent with our previous findings that LRRK2 stimulates IL-1β-mediated downstream signaling, the two PD-associated mutants, having enhanced kinase activities, stimulated NF-κB activity more than did their wild-type counterpart (Figure 7E).